We suspected that the greater in vivo tumor targeting might be due to the higher penetrability of small molecular antibody and the characteristic of accumulation in malignant and inflammatory tissues of HSA,75–78 but the exact mechanism was unclear and in need of an accurate measure of pharmacokinetics and further verification. Here, ALB is linked to neoplasm.